HK Stock Market Move | AK MEDICAL (01789) is now up more than 6%, and the comprehensive implementation of the renewal policy for centralized procurement is expected to accelerate performance in the second half of the year.

AK MEDICAL (01789) is currently up over 6%, as of the time of writing, up 4.34% at $6.25 Hong Kong dollars, with a turnover of 32.2594 million Hong Kong dollars. China Securities Co., Ltd. released a research report stating that looking forward to the second half of 2025, with the implementation of the national policy of continued procurement of artificial joints, the industry price system is tending to stabilize. The company has won bids with increased prices for hip and knee joints in this round of renewals, and the logic of rising volume and price is expected to be realized. At the same time, the volume of orthopedic surgeries is expected to rebound, and with the company's revenue base not high in the second half of last year, it is expected that the company's performance will show a trend of low at first and then high, with the possibility of achieving high-speed growth in the second half of the year. The bank pointed out that in the medium to long term, the company's forward-looking layout in innovative products such as 3D printing, Siasun Robot & Automation, and the digital orthopedic ecosystem will build a solid technological barrier and open up new growth space. In the overseas market, with the deepening of the "JRI + AK Medical" dual brand strategy and the continued progress of product registration, the overseas business is expected to become a strong growth engine for the company.